INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 206S206 trades$1.10M
  3. 03SPSaba Capital Management, L.P.71B / 19S · 11 late90 trades$22.56M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 36S38 trades$22.91M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,367 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
41
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$445K
56.6K sh
Dec 3, 2025Dec 18, 2025
Page 1607 of 1835
← PrevNext →
traded Dec 3, 2025
+15d
SEC Form 4

Evidence

40
RF
Rankin Aaron Edward FrederickDirector, 10% Owner
SPTSprout Social, Inc.
Open-market purchase · 10b5-1 plan
BUY$1.01M
90.7K sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

38
AM
Autor Deborah M.Director, Chief Policy Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$259K
7,054 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

38
BI
Becklund IrenePAO
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$309K
8,411 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

37
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$490K
72.7K sh
Dec 4, 2025Dec 18, 2025
traded Dec 4, 2025
+14dSEC Form 4

Evidence

37
CD
Colpman DavidDirector
ELUTELUTIA INC.
Open-market purchase
BUY$6,375
12.5K sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

36
SR
Schaffer RyanDirector, Chief Financial Officer
EXFYExpensify, Inc.
Open-market sale
SELL$4,080
2,632 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

36
MA
Muralidharan AnuradhaDirector, Chief Operating Officer
EXFYExpensify, Inc.
Open-market sale
SELL$811
523 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

36
MF
Mills Jason FahrDirector
EXFYExpensify, Inc.
Open-market sale
SELL$9,072
5,853 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

36
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.27M
18.3K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

36
MJ
Morrissey Michael JamesEVP, Head of Tech. Operations
INCYINCYTE CORP
Open-market sale · 10b5-1 plan
SELL$5.17M
53.2K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

34
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$221K
37.2K sh
Dec 5, 2025Dec 18, 2025
traded Dec 5, 2025
+13dSEC Form 4

Evidence

33
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$925K
13.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

32
BM
Barrett David MichaelDirector, Chief Executive Officer
EXFYExpensify, Inc.
Open-market sale
SELL$3,943
2,544 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

32
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$5.07M
23.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

32
VD
Vidal DanielDirector
EXFYExpensify, Inc.
Open-market sale
SELL$7,497
4,837 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

30
NH
Nussdorf Glenn HDirector
ORGOOrganogenesis Holdings Inc.
Open-market sale
SELL$1.03M
200.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

30
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale
SELL$304K
3,984 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

30
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$122K
21.5K sh
Dec 8, 2025Dec 18, 2025
traded Dec 8, 2025
+10dSEC Form 4

Evidence

30
MK
McCarthy Brian K.Pres.,Global Sales & Field Ops
RBRKRubrik, Inc.
Open-market sale
SELL$148K
1,946 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

30
CH
Carroll Patrick HarrisonDirector, Chief Medical Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$368K
10.0K sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

30
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$89K
15.0K sh
Dec 9, 2025Dec 18, 2025
traded Dec 9, 2025
+9dSEC Form 4

Evidence

30
MK
McCarthy Brian K.Pres.,Global Sales & Field Ops
RBRKRubrik, Inc.
Open-market sale
SELL$217K
2,851 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

30
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$64K
9,921 sh
Dec 10, 2025Dec 18, 2025
traded Dec 10, 2025
+8dSEC Form 4

Evidence

29
RR
Radabaugh Mark R.PRESIDENT/CEO OF AMPLEX
OMCCOLD MARKET CAPITAL Corp
Open-market purchase
BUY$549
100 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

29
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$103K
699 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

29
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$253K
3,600 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

29
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$84K
578 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

29
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$97K
1,767 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

29
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$134K
951 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

29
RR
Radabaugh Mark R.PRESIDENT/CEO OF AMPLEX
OMCCOLD MARKET CAPITAL Corp
Open-market purchase
BUY$11K
2,000 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

29
SM
Saintil MerlineDirector
RKLBRocket Lab Corp
Open-market sale · 10b5-1 plan
SELL$136K
2,533 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

28
SP
Streck PaulEVP, Head of R&D
PEPGPepGen Inc.
Grant or award
A—
40.0K sh
Nov 4, 2025Dec 18, 2025
traded Nov 4, 2025
+44dSEC Form 4

Evidence

28
KJ
Knowles JuliusDirector
KROSKeros Therapeutics, Inc.
Disposition to issuer
D$3.40M
191.5K sh
Nov 21, 2025Dec 18, 2025
traded Nov 21, 2025
+27dSEC Form 4

Evidence

28
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$1.03M
4,675 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

28
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$2.06M
9,270 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

28
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$2.20M
9,804 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

28
KJ
Knowles JuliusDirector
KROSKeros Therapeutics, Inc.
Disposition to issuer
D$2.32M
130.5K sh
Nov 21, 2025Dec 18, 2025
traded Nov 21, 2025
+27dSEC Form 4

Evidence

27
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale
SELL$213K
2,795 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

26
CM
Chi MichaelChief Operating Officer
HIMSHims & Hers Health, Inc.
Open-market sale · 10b5-1 plan
SELL$505K
13.8K sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence